| Literature DB >> 23772037 |
Angela S Archambault1, Javier A Carrero, Lisa G Barnett, Nigel G McGee, Julia Sim, Jonathan O Wright, Tobias Raabe, Peiquin Chen, Hua Ding, Eric J Allenspach, Ioannis Dragatsis, Terri M Laufer, Gregory F Wu.
Abstract
The activation, differentiation, and subsequent effector functions of CD4 T cells depend on interactions with a multitude of MHC class II (MHCII)-expressing APCs. To evaluate the individual contribution of various APCs to CD4 T cell function, we have designed a new murine tool for selective in vivo expression of MHCII in subsets of APCs. Conditional expression of MHCII in B cells was achieved using a cre-loxP approach. After i.v. or s.c. priming, partial proliferation and activation of CD4 T cells was observed in mice expressing MHCII only by B cells. Restricting MHCII expression to B cells constrained secondary CD4 T cell responses in vivo, as demonstrated in a CD4 T cell-dependent model of autoimmunity, experimental autoimmune encephalomyelitis. These results highlight the limitations of B cell Ag presentation during initiation and propagation of CD4 T cell function in vivo using a novel system to study individual APCs by the conditional expression of MHCII.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23772037 PMCID: PMC3711531 DOI: 10.4049/jimmunol.1201598
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422